PHARMACEUTICALS USE PREGNANCY

Brand Owner (click to sort) Address Description
MIFEGYMISO LINEPHARMA 101 AVENUE OF THE AMERICAS, SUITE 800 NEW YORK NY 10013 pharmaceuticals for use in pregnancy termination;
MIFEGYMISO LINEPHARMA INTERNATIONAL 101 AVENUE OF THE AMERICAS, SUITE 800 NEW YORK NY 10013 pharmaceuticals for use in pregnancy termination;
WHP Women Health Protection Suite 800 101 Avenue of the Americas New York NY 10013 pharmaceuticals for use in pregnancy termination;WOMEN HEALTH PROTECTION;
WOMEN HEALTH PROTECTION Women Health Protection Suite 800 101 Avenue of the Americas New York NY 10013 pharmaceuticals for use in pregnancy termination;WOMEN HEALTH;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Disclosed is a maternity biodata measurement system, wherein a sum of a pre-pregnancy energy expenditure and a pregnancy extra energy amount of a subject is determined as an energy amount necessary for the subject in a pregnancy period. In particular, the pregnancy extra energy amount is determined based on pre-pregnancy body-mass index data and elapsed pregnancy-period data about the subject, so as to allow the necessary energy amount to be determined as a value appropriate for the subject. The maternity biodata measurement system of the present invention makes it possible to measure a necessary energy amount for a pregnant woman on an individual basis.